MICHAEL LOSHIGIAN, DPM
Podiatrist in FRESH MEADOWS, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MICHAEL LOSHIGIAN, DPM filed 564 Medicare Part D claims in 2023 as a Podiatrist in FRESH MEADOWS, New York, prescribing 96% generic.
- 564
- Part D claims, 2023
- 96%
- generic prescribing
- $726.26
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MICHAEL LOSHIGIAN, DPM's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
564 Top 34% higher than 66% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about MICHAEL LOSHIGIAN, DPM?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in New York
How Podiatrist compares to other specialties among New York providers
Podiatrist share within New York
Podiatrist is one of the more visible NUCC categories in New York
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Podiatrist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Podiatrist ABMS/AOA estimate
Est. board-certified rate (Podiatrist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Podiatrist US NPIs
Specialty board-certified rate — Podiatrist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MICHAEL LOSHIGIAN, DPM appears in the CMS NPPES registry as a Podiatrist provider holding DPM credentials at 17926 UNION TPKE, FRESH MEADOWS, NY, 11366, with a listed phone of (718) 380-7900. NPI 1235139106 was issued on 07/21/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LOSHIGIAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 564 prescription claims written by this provider, covering 195 Medicare beneficiaries and totaling roughly $46K in drug spend, split 4% brand-name and 96% generic by claim count, with an opioid prescribing rate of 4.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Podiatrist is a mid-sized specialty nationwide, with 10,498 enrolled providers across 54 states and an average of 304 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1235139106 |
|---|---|
| Specialty | Podiatrist |
| Credentials | DPM |
| Gender | Male |
| NPI Issued | 07/21/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MICHAEL LOSHIGIAN, DPM's current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where MICHAEL LOSHIGIAN, DPM bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MICHAEL LOSHIGIAN, DPM. Source: openpaymentsdata.cms.gov.
Total received
$726
Largest payer
Stryker Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — New York NYSBPMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MICHAEL LOSHIGIAN, DPM. To verify MICHAEL LOSHIGIAN, DPM's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
4% brand-name claims vs 96% generic, on 564 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 646
- Total Day Supply
- 16,541
- Brand vs Generic
- 4% brand / 96% generic
- Brand Drug Cost
- $38K
- Generic Drug Cost
- $8K
- Opioid Claims
- 24 (4.3% rate)
- Antibiotic Claims
- 37
Patient Demographics
- Average Patient Age
- 74.0 years
- Avg HCC Risk Score
- 1.07
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 11, 65-74: 94, 75-84: 72, 85+: 18
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MICHAEL LOSHIGIAN, DPM prescribes most
Top Medicare Part D drugs by claim count, 2023
- Nystatin
Nystatin
262 claims
- Terbinafine Hcl 72
Terbinafine Hcl
72 claims
- Gabapentin 32
Gabapentin
32 claims
- Meloxicam 23
Meloxicam
23 claims
- Diclofenac Sodium 17
Diclofenac Sodium
17 claims
- Fluconazole 15
Fluconazole
15 claims
- Oxycodone Hcl 13
Oxycodone Hcl
13 claims
- Cefadroxil 12
Cefadroxil
12 claims
| Drug | Claims |
|---|---|
| Nystatin | 262 |
| Terbinafine Hcl | 72 |
| Gabapentin | 32 |
| Meloxicam | 23 |
| Diclofenac Sodium | 17 |
| Fluconazole | 15 |
| Oxycodone Hcl | 13 |
| Cefadroxil | 12 |
| Jublia Efinaconazole | 11 |
| Triamcinolone Acetonide | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Podiatrist Overview
How MICHAEL LOSHIGIAN, DPM fits within the Podiatrist landscape nationally.
MICHAEL LOSHIGIAN, DPM's 564 claims are above the specialty average of 304.
Nearby Podiatrist Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as LOSHIGIAN.
Compare Podiatrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New York
Frequently Asked Questions
What is MICHAEL LOSHIGIAN, DPM's specialty? ▼
How much does MICHAEL LOSHIGIAN, DPM prescribe under Medicare Part D? ▼
Where is MICHAEL LOSHIGIAN, DPM located? ▼
What is MICHAEL LOSHIGIAN, DPM's NPI number? ▼
Does MICHAEL LOSHIGIAN, DPM prescribe more brand-name or generic drugs? ▼
Does MICHAEL LOSHIGIAN, DPM prescribe opioids? ▼
How many Podiatrist providers are there in the US? ▼
What drugs does MICHAEL LOSHIGIAN, DPM prescribe most often? ▼
Does MICHAEL LOSHIGIAN, DPM accept Medicare? ▼
How can I verify MICHAEL LOSHIGIAN, DPM's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology